Xencor (XNCR) EBITDA Margin (2013 - 2026)
Xencor (XNCR) reported EBITDA Margin of -67.61% for Q2 2026, up 2.38 percentage points from -69.98% a year earlier and up 1599.69 percentage points from the prior quarter.
Powered by 
Analysis
Xencor (XNCR) EBITDA Margin (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Xencor's EBITDA Margin came in at -196.15%, down 105.40 percentage points year-over-year; for FY2025, it was -132.98%, up 17.53 percentage points from FY2024.
- EBITDA Margin has a five-year change of -75.11 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at -150.51% in FY2024 (-81.29 pp), -69.22% in FY2023 (-24.46 pp), -44.76% in FY2022 (-63.39 pp) and 18.63% in FY2021 (+76.50 pp).
- The Q2 2026 figure ranks as the highest quarterly EBITDA Margin since Q4 2024.
- Year over year, EBITDA Margin gained in five of the last eight quarters, with an average year-over-year change of -189.38 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q1 2025 (a gain of 199.03 percentage points); the low point was Q1 2026 (a drop of 1543.59 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -1667.29% (Q1 2026), -180.79% (Q4 2025) and -213.96% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Xencor | 2.94 Bn | 1.37 Bn | - | 21.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 21.54% |
| Jun 30, 2026 | -67.61% |
| Mar 31, 2026 | -1,667.29% |
| Dec 31, 2025 | -180.79% |
| Sep 30, 2025 | -213.96% |
| Jun 30, 2025 | -69.98% |
| Mar 31, 2025 | -123.70% |
| Dec 31, 2024 | -19.29% |
| Sep 30, 2024 | -293.00% |
| Jun 30, 2024 | -218.96% |
| Mar 31, 2024 | -322.74% |
| Dec 31, 2023 | -47.33% |
| Sep 30, 2023 | -25.56% |
| Jun 30, 2023 | -50.77% |
| Mar 31, 2023 | -307.89% |
| Dec 31, 2022 | -187.19% |
| Sep 30, 2022 | -132.27% |
| Jun 30, 2022 | -85.35% |
| Mar 31, 2022 | 33.50% |
| Dec 31, 2021 | 60.88% |
API Access
Xencor EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=XNCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "XNCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=XNCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();